Structure-based classification predicts drug response in <i>EGFR</i>-mutant NSCLC

Structure-based classification predicts drug response in <i>EGFR</i>-mutant NSCLC

Nature, Published online: 15 September 2021; doi:10.1038/s41586-021-03898-1

Structural classification of mutations in the epidermal growth factor receptor causing non-small cell lung cancer is a better predictor of patient outcomes following drug treatment than traditional exon-based classification.
Source: Nature